PMID: 11011992Sep 30, 2000Paper

Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective beta2-adrenergic radioligand

International Journal of Pharmaceutics
R M MorescoF Fazio

Abstract

Erytro-(+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[ iso-propylamino]-2-butanol (ICI 118551) a potent clinically used beta2 adrenergic antagonist, was labelled with carbon-11 (t1/2 = 20.4 min) as a potential radioligand for the non-invasive assessment of beta2 adrenergic receptors in the lung with positron emission tomography (PET). The radiolabelled compound was prepared by reductive N-alkylation of its des-isopropyl precursor with [2-11C]acetone. (+/-)-[11C]ICI 118551 was obtained in greater than 98% radiochemical purity in 30 min with a radiochemical yield of 15 + 5% (non-decay corrected) and a specific radioactivity 2.5 +/- 0.5 Ci/micromol. The biological evaluation of racemic erythro (+/-)-[11C]ICI 118551 in rats and Macaca Nemestrina shows a high radioactivity uptake in lung and heart. However, in both animal models no detectable displacement of lung radioactivity concentration was observed after pre-treatment with propranolol or ICI 118551, which indicates that in this organ, radioligand uptake is mostly due to non-specific binding. The biological data suggest that erythro (+/-)-[11C]ICI 118551 is not adequate to be further developed as a tracer for beta2 adrenergic receptor imaging in vivo.

References

May 1, 1976·British Journal of Pharmacology·C T Dollery, A F Junod
Jul 1, 1992·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·M S BerridgeJ M Vesselle
Sep 1, 1991·Journal of Neurochemistry·B H Erdtsieck-ErnsteG J Boer
May 1, 1981·British Journal of Pharmacology·B A Hemsworth, J A Street
May 7, 1998·European Journal of Pharmacology·A Van WaardeW Vaalburg
Jun 26, 1999·Nuclear Medicine and Biology·A R StudenovS Todde

Related Concepts

ICI 118551, hydrochloride
Adrenergic beta-Antagonists
Metazoa
Carbon Radioisotopes
Lung
Macaca nemestrina
Propanolamines
Drug or Chemical Tissue Distribution
Tomography, Emission-Computed
Beta-2 Adrenergic Receptors

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.